Tackling Neurodegeneration in MS Through A1 Antibodies
Dr. Michael Levin, professor of neurology at the University of Saskatchewan, discussed his presentation at the 2022 CMSC Annual Meeting on using ribonucleoprotein A1 antibodies to drive neurodegeneration in multiple sclerosis.
Watch the clip here.